Navigation Links
Reportlinker Adds Global Bladder Cancer Therapeutics Industry
Date:11/18/2010

and Scandinavia (includes corresponding Graph/Chart) III-24

Europe Lacks R&D Innovation in Bladder Cancer Market III-24

Focus on Select Regional Market III-24

United Kingdom III-24

Bladder Cancer Prevalence - A Review III-24

Bladder Cancer Statistics in the UK III-25

Table 23: Incidence, Mortality, and Five-Year Survival

Rate of Bladder Cancer in UK by Gender: 2006 III-25

Table 24: Bladder Cancer Incidence by Region (2006) for

England, Wales, Scotland, and Northern Ireland (includes

corresponding Graph/Chart) III-25

Table 25: Age-Specific Incidence of Bladder Cancer by

Gender: 2006 (includes corresponding Graph/Chart) III-25

Table 26: Number of Bladder Cancer Deaths in the UK

(2007): Breakdown by Region - England, Wales, Scotland,

and Northern Ireland (includes corresponding Graph/Chart) III-26

Table 27: Age-Specific Bladder Cancer Mortality Rate in UK

Males: Breakdown by Age Group for 2007 (includes

corresponding Graph/Chart) III-26

Table 28: Age-Specific Bladder Cancer Mortality Rate in UK

Females: Breakdown by Age Group for 2007 (includes

corresponding Graph/Chart) III-26

Strategic Corporate Developments III-26

Select Players III-28

Affitech A/S (Denmark) III-28

Astrazeneca PLC (UK) III-28

BioCis Pharma Ltd (Finland) III-29

Cambridge Laboratories Ltd. (UK) III-29

curasan AG (Germany) III-29

Cytavis BioPharma GmbH (Germany) III-29

ENKAM Pharmaceuticals A/S (Denmark) III-30

F. Hoffmann-La Roche Ltd. (Switzerland) III-30

Laboratoires Pierre Fabre SA (France) III-30

NatImmune A/S (Denmark) III-31

Sanofi-Aventis (France) III-31

Telormedix SA (Switzerland) III-32

B.Market Analytics III-33

Table 29: European Recent Past, Current and Future Analysis

for Bladder Cancer Therapeutics - Annual Revenues
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Reportlinker Adds Infectious Disease Molecular Diagnostic Testing
2. Reportlinker Adds Smart Glass: Technologies and Global Markets Report
3. Reportlinker Adds Synthetic Biology: Emerging Global Markets Report
4. Reportlinker Adds Proteomics: Technologies and Global Markets Report
5. Reportlinker Adds Nanomedicine Report
6. Reportlinker Adds Small Molecule Kinase Inhibitors Report
7. Reportlinker Adds Nanoporous Materials Report
8. Reportlinker Adds Membrane Bioreactors Report
9. Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement
10. Reportlinker Adds High-Tech Patient Monitoring Systems Markets (Remote and Wireless Systems, Data Processing, EMR Data Transfer) Report
11. Reportlinker Adds In Vitro Diagnostics in a Recession: IVD Market Forecasts, Analysis and Success Strategies Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... 2014 /PRNewswire/ - iCo Therapeutics ("iCo" or "the Company") ... for its Oral Amphotericin B program.  The company ... vitro work involving samples from HIV/AIDS patients ... complete pre clinical studies and regulatory filings to ... trial, utilizing approximately $700,000 of funding and technological ...
(Date:10/22/2014)... 22, 2014 Research and Markets  has ... by Material, by Application, Geography - Global Analysis and ... Organic electronics, also called as polymer ... science which deals with small conductive molecules and electrically ... molecules and polymers are carbon based, made using synthetic ...
(Date:10/20/2014)... The report “Pharmacy Automation Systems ... and Labeling Systems, Table-top Counters) by End-user (Inpatient ... & Trends to 2019” analyzes and studies the ... America, Europe, Asia-Pacific, and the Rest of the ... 30 figures spread through 300 pages and in-depth ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 Convey ... that a team from Iowa State University won first ... contest. Using a Convey HC-2ex, the team’s solution achieved ... times faster than the second place finisher. , Experts ... embarked upon the month long challenge, using a variety ...
Breaking Biology Technology:iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 2iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 3Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 2Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 2Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 3
... Interleukin Genetics,Inc. (Amex: ILI ), announced today that ... August 13, 2008, at 8:30 a.m. EDT to review ... update on,recent corporate developments., To access the live ... and replay access of the teleconference,will be available on ...
... announced today that,it has updated coverage and has issued ... INO ). "The proposed merger of Inovio and VGX,would ... deliver,therapeutic agents and positions Inovio/VGX, based on further development,progress, ... gene therapy,companies," said Ross Silver, Director of Research for ...
... Inc.,(Nasdaq: NXTM ), a leading manufacturer of ... Chief Executive Officer and Robert,Brown, Chief Financial Officer, ... Where possible, a webcast of each event will ... time of each,conference., Canaccord Adams Annual ...
Cached Biology Technology:Interleukin Genetics Announces Conference Call and Webcast to Discuss Second Quarter 2008 Business Results 2Vista Partners Updates Coverage on Inovio Biomedical Corporation (Amex: INO); $3.57 Price Target 2NxStage Announces Investor Conference Schedule 2
(Date:10/22/2014)... -- Aware, Inc. (NASDAQ: AWRE ), a leading ... for its third quarter ended September 30, 2014. ... an increase of 40% compared to $4.3 million in the ... of 2014 was $4.1 million compared to $1.0 million in ... current three month period was primarily due to: i) a ...
(Date:10/18/2014)... a sample of patients with undiagnosed, suspected genetic conditions, ... with a higher molecular diagnostic yield than traditional molecular ... JAMA . The study is being released to coincide ... , Exome sequencing, which sequences the protein­coding region of ... material present in a cell or organism), has been ...
(Date:10/17/2014)... German . To ... treating overdoses, doctors are often limited to supportive therapy such ... a combination of drugs involved. So what can be done ... pills? ETH professor Jean-Christophe Leroux from the Institute of Pharmaceutical ... this question. "The task was to develop an agent that ...
Breaking Biology News(10 mins):Aware, Inc. Reports Third Quarter 2014 Financial Results 2Aware, Inc. Reports Third Quarter 2014 Financial Results 3Aware, Inc. Reports Third Quarter 2014 Financial Results 4Aware, Inc. Reports Third Quarter 2014 Financial Results 5Aware, Inc. Reports Third Quarter 2014 Financial Results 6Aware, Inc. Reports Third Quarter 2014 Financial Results 7Study examines type of exome sequencing and molecular diagnostic yield 2Study examines type of exome sequencing and molecular diagnostic yield 3Emergency aid for overdoses 2Emergency aid for overdoses 3
... steelhead trout in hatcheries causes a dramatic and unexpectedly ... wild, a new Oregon State University study shows, and ... practices. The research, to be published Friday in ... the reproductive success of steelhead trout, an important salmonid ...
... is reined in prevented from giving up its ... presence of a protein modification that stifles any genes ... heart or other specialized tissue. But, thanks to the ... primed and poised, ready to develop into specialized body ...
... WHAT: The 2007 Prostate Cancer Foundation Scientific Retreat will ... prostate cancer. Presentations include discoveries expected to lead ... help men avoid developing prostate cancer. ... share new research on how eating common foods such ...
Cached Biology News:Salmonid hatcheries cause 'stunning' loss of reproduction 2Salmonid hatcheries cause 'stunning' loss of reproduction 3Human embryonic stem cells remain embryonic because of epigenetic factors 2Human embryonic stem cells remain embryonic because of epigenetic factors 3New prostate cancer research findings 2
... The Agilent One-Color RNA Spike-In Kit ... specifically anneal only to complementary control probes ... cross-hybridization. The spike-ins serve as a positive ... NOTE: This kit is a ...
... spatulas have been designed to save time ... those interested in eliminating the recycling and ... is individually packaged, RNase/DNase free, non-pyrogenic and ... new product number, created to easily match ...
... use spatulas have been designed to save ... for those interested in eliminating the recycling ... spatula is individually packaged, RNase/DNase free, non-pyrogenic ... a new product number, created to easily ...
... CHEMICONs Alkaline Phosphatase Detection Kit (Catalog ... tool for the phenotypic assessment of ES ... activity. Available separately from CHEMICON are ... and TRA-2-54 (Catalog Number MAB4354), which permit ...
Biology Products: